Collegium Pharmaceutical Files 8-K

Ticker: COLL · Form: 8-K · Filed: Jul 7, 2025 · CIK: 1267565

Collegium Pharmaceutical, Inc 8-K Filing Summary
FieldDetail
CompanyCollegium Pharmaceutical, Inc (COLL)
Form Type8-K
Filed DateJul 7, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, 8-k

TL;DR

Collegium Pharma filed a routine 8-K on July 1st. No major news.

AI Summary

On July 1, 2025, Collegium Pharmaceutical, Inc. filed an 8-K report. The filing indicates no specific material events or changes requiring immediate disclosure beyond routine reporting. The company's principal executive offices are located at 100 Technology Center Drive, Stoughton, MA 02072.

Why It Matters

This 8-K filing serves as a notification to investors about significant corporate events. While this specific filing appears routine, it's crucial for tracking company updates and potential material disclosures.

Risk Assessment

Risk Level: low — The filing is a standard 8-K report and does not disclose any new material risks or adverse information.

Key Players & Entities

  • COLLEGIUM PHARMACEUTICAL, INC. (company) — Registrant
  • July 1, 2025 (date) — Date of earliest event reported
  • 100 Technology Center Drive Suite 300 (address) — Principal executive offices
  • Stoughton, MA 02072 (address) — Principal executive offices
  • 781-713-3699 (phone_number) — Registrant's telephone number

FAQ

What is the primary purpose of this 8-K filing for Collegium Pharmaceutical, Inc.?

The primary purpose of this 8-K filing is to report current information about significant corporate events as required by the Securities Exchange Act of 1934.

On what date was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on July 1, 2025.

Where are Collegium Pharmaceutical, Inc.'s principal executive offices located?

Collegium Pharmaceutical, Inc.'s principal executive offices are located at 100 Technology Center Drive, Suite 300, Stoughton, MA 02072.

What is the telephone number for Collegium Pharmaceutical, Inc. as listed in the filing?

The telephone number for Collegium Pharmaceutical, Inc. is (781) 713-3699.

Does this 8-K filing disclose any specific material events or changes?

Based on the provided text, this 8-K filing does not appear to disclose any specific material events or changes beyond routine reporting requirements.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 7, 2025 regarding COLLEGIUM PHARMACEUTICAL, INC (COLL).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.